Skip to content

Disc Medicine IRON Current ratio

Current ratio at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
1.4×+0.1×
Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
+0.4×
Protagonist Therapeutics logo
Protagonist TherapeuticsPTGX
17.8×+0.5×
Agios Pharmaceuticals logo
Agios PharmaceuticalsAGIO
14.2×-4.3×
Beam Therapeutics logo
Beam TherapeuticsBEAM
17×+8.2×
Travere Therapeutics, Inc. logo
Travere Therapeutics, Inc.TVTX
3.1×+1.1×

Other financials

Income statement

See full
Operating income-$69.5M-74.0%
Net income-$63.5M-86.3%
EPS (diluted)-$1.65-61.8%

Balance sheet

See full
Cash & equivalents$88.9M-27.5%
Total debt$31.1M+1.4%
Total equity$688.4M+4.3%
Total assets$750.2M+5.8%

Cash flow

See full
Operating cash flow-$62.2M-50.4%
CapEx--100%
Free cash flow-$62.2M-47.4%

Valuation

See full
Market cap$2.69B+42.2%
Enterprise value$2.63B+46.7%

Returns & leverage

See full
Return on equity-35.8%+41.3pp
Debt / equity0.0×

Where this comes from

Calculated from Disc Medicine’s reported figures.

Based on the most recent quarter.

The official record: Disc Medicine’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Disc Medicine's current ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Disc Medicine's current ratio?
Disc Medicine (IRON) reported current ratio of 24× in Q1 2026.
How has Disc Medicine's current ratio changed year-over-year?
Disc Medicine's current ratio decreased by 36.3% year-over-year, from 37.7× to 24×.
What is the long-term trend for Disc Medicine's current ratio?
Over 5 years (2020 to 2025), Disc Medicine's current ratio has grown at a 155.0% compound annual growth rate (CAGR), from 0.2× to 21.9×.
What does current ratio mean?
Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.